Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Association of Cd24v/V Genotype With Susceptibility and Progression of Multiple Sclerosis in Iranian Population



Ronaghi M1 ; Vallian S1 ; Etemadifar M2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Biology, Division of Genetics, University of Isfahan, Isfahan, P.O. Box 81746-73441, Iran
  2. 2. Department of Neurosciences, Isfahan University of Medical Sciences, Isfahan, P.O. Box 81746-73461, Iran

Source: Iranian Journal of Biotechnology Published:2008

Abstract

A single nucleotide polymorphism (SNP) in CD24 has been associated with multiple sclerosis (MS) in a population based study. This SNP results in the replacement of alanine (CD24A) by valine (CD24V) at amino acid 57 in the resulting polypeptide chain. In the current study, the genotyping of this SNP and its contribution to MS in 217 patients and 200 healthy individuals of an Iranian population was investigated. The correlation of the SNP alleles with the progression of the disease was determined using the expanded disability status scale (EDSS) and progression index (PI). The data revealed that individuals with the CD24V/V genotype showed a 2-fold increase in the relative risk of MS compared to patients with the CD24A/V (0.27) and CD24A/A (0.25) genotypes (P = 0.0193, Odds Ratio 2.4882, 95% CI: 1.416-4.3722). Moreover, the progression of the disease in patients with CD24V/V was much faster than other patients that were examined by ANOVA and the least significant difference (LSD) test. However, in the CD24V/V patients LSD analysis was statistically significant (p<0.05 and p<0.01). These results support the hypothesis that CD24 may function as a genetic modifier for susceptibility and progression of MS through the CD24V/V genotype.
Related Docs
View other Related Docs
1. Cd24 Gene Allele Variation Is Not Associated With Oligoclonal Igg Bands and Igg Index of Multiple Sclerosis Patients, NeuroImmunoModulation (2012)
2. High-Resolution Melting Curve Analysis of Polymorphisms Within Cd58, Cd226, Hla-G Genes and Association With Multiple Sclerosis Susceptibility in a Subset of Iranian Population: A Case–Control Study, Acta Neurologica Belgica (2020)
3. Risk Factor Effect of Rs1044165 and Rs3745453 As Neighboring Variants of Mir-223, Mir-24, Mir-23A and Mir-27A on the Onset of Ms Disease in Isfahan/Iran, Gene Reports (2018)
4. Polymorphism of Apolipoprotein E Gene and the Risk of Multiple Sclerosis, Journal of Research in Medical Sciences (2011)
5. Interleukin 18 Polymorphisms and Its Serum Level in Patients With Multiple Sclerosis, Annals of Indian Academy of Neurology (2019)
6. An Interdependence Between Gapvd1 Gene Polymorphism, Expression Level and Response to Interferon Beta in Patients With Multiple Sclerosis, Journal of Neuroimmunology (2021)
7. Association of Interleukin-1 Gene Cluster Polymorphisms and Haplotypes With Multiple Sclerosis in an Iranian Population, Journal of Neuroimmunology (2015)
8. Genetic Variation in Intergenic and Exonic Mirna Sequence and Risk of Multiple Sclerosis in the Isfahan Patients, Iranian Journal of Allergy, Asthma and Immunology (2018)
Experts (# of related papers)
View all Related Experts
Masoud Etemadifar (76)
Vahid Shaygannejad (75)
Other Related Docs
9. Association of Aire Polymorphism and the Susceptibility to Multiple Sclerosis in Iranian Population, Avicenna Journal of Medical Biotechnology (2018)
10. The Frequency of Tim-3-1541C>T Polymorphisms and Its Association With Multiple Sclerosis, Journal of Isfahan Medical School (2015)
11. Comparing the Frequency of Tim-3 Polymorphism in Multiple Sclerosis Patients With Healthy Controls, Journal of Isfahan Medical School (2015)
12. Evaluation of the Frequency of Osteopontin Gene Polymorphism (Rs28357094 T>G) and Its Receptor Gene (Itga4- Rs1449263 A>G) in Multiple Sclerosis Patients in Comparison to Healthy Controls in Isfahan, Iran, Population, Journal of Isfahan Medical School (2016)
13. The Role of Non-Hla Single Nucleotide Polymorphisms in Multiple Sclerosis Susceptibility, Journal of Neuroimmunology (2010)
14. Epidemiology of Multiple Sclerosis in Iran: A Systematic Review, European Neurology (2013)
15. Prevalence and Incidence of Multiple Sclerosis in Isfahan, Iran Between 1996 and 2021: A Population-Based Study, Multiple Sclerosis and Related Disorders (2024)
16. Clinical Characteristics and Disability Progression of Early-And Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis, Journal of Clinical Medicine (2020)
17. Evaluation of Serum and Urinary Cystatin C Concentrations and Their Relationship With Edss in Patients With Multiple Sclerosis, Tehran University Medical Journal (2011)
18. Incidence and Prevalence of Multiple Sclerosis in Persian Gulf Area: A Systematic Review and Meta-Analysis, Multiple Sclerosis and Related Disorders (2020)
19. Multiple Sclerosis in Isfahan, Iran, International Review of Neurobiology (2007)
20. Multiple Sclerosis Epidemiology in Asia and Oceania; a Systematic Review and Meta-Analysis, Multiple Sclerosis and Related Disorders (2021)
21. Investigation of Erg Gene Expression in Iranian Patients With Multiple Sclerosis, Immunological Investigations (2018)
22. The Prevalence of the Genetic Polymorphism of Gstm1, Gstt1 and Gstp1 and Its Relationship With Clinical Criteria of Multiple Sclerosis (Ms) Patients in Tehran, Journal of Babol University of Medical Sciences (2019)
23. Sharp Increase in the Incidence and Prevalence of Multiple Sclerosis in Isfahan, Iran, Multiple Sclerosis Journal (2011)
24. Il-23 Plasma Level Measurement in Relapsing Remitting Multiple Sclerosis (Rrms) Patients Compared to Healthy Subjects, Immunological Investigations (2015)
25. Polymorphism in Leptin and Leptin Receptor Genes May Modify Leptin Levels and Represent Risk Factors for Multiple Sclerosis, Immunological Investigations (2016)
26. The +4259A>C Polymorphism of Tim-3 But Not -1637C>T Polymorphism of Tim-1 Is Associated With Multiple Sclerosis in Isfahan Population, Multiple Sclerosis and Related Disorders (2017)
27. Toll Like Receptor 2 and 4 Expression in Peripheral Blood Mononuclear Cells of Multiple Sclerosis Patients, Iranian Journal of Immunology (2014)
28. Interdependency of Ninj2 Gene Expression and Polymorphism With Susceptibility and Response to Interferon Beta in Patients With Multiple Sclerosis, International Journal of Neuroscience (2024)
29. Association of Tim-1 5383-5397Ins/Del and Tim-3 -1541C>T Polymorphisms With Multiple Sclerosis in Isfahan Population, International Journal of Immunogenetics (2016)
30. Risk Factors of Multiple Sclerosis and Their Relation With Disease Severity: A Cross-Sectional Study From Iran, Archives of Iranian Medicine (2016)
31. Rit2 Polymorphisms: Is There a Differential Association?, Molecular Neurobiology (2017)
32. Lncrnas Associated With Multiple Sclerosis Expressed in the Th1 Cell Lineage, Journal of Cellular Physiology (2019)
33. Rituximab and Glatiramer Acetate in Secondary Progressive Multiple Sclerosis: A Randomized Clinical Trial, Acta Neurologica Scandinavica (2021)
34. Conjugal Multiple Sclerosis in Isfahan, Iran: A Population-Based Study, Multiple Sclerosis (2007)
35. An Investigation Into the Association Between Hla-G 14Bp Insertion/Deletion Polymorphism and Multiple Sclerosis Susceptibility, Journal of Neuroimmunology (2016)
36. The Comparative Analysis of Serum Levels of Midkine in Patients With Multiple Sclerosis and Control Group, Journal of Isfahan Medical School (2013)
37. Comparison of Interferon Beta Products and Azathioprine in the Treatment of Relapsing-Remitting Multiple Sclerosis, Journal of Neurology (2007)
38. Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis: An International Registry Study, Neurology (2022)
39. Prognostic Value of Intrathecal Igg Synthesis in Multiple Sclerosis: A Study in 54 Patients, Tehran University Medical Journal (2008)
40. Serum Uric Acid Level in Patients With Relapsing-Remitting Multiple Sclerosis, Journal of Clinical Neuroscience (2013)
41. Prescription Trends of Disease-Modifying Treatments for Multiple Sclerosis in Iran Over the Past 30 Years, Multiple Sclerosis and Related Disorders (2022)
42. Single Nucleotide Polymorphism Rs6445975 in the Pxk Gene Is Correlated With Susceptibility and Clinical Characteristics of Systemic Lupus Erythematosus, Iranian Journal of Public Health (2022)
43. 25-Hydroxyvitamin D Concentrations in Patients With Optic Neuritis As a Clinically Isolated Syndrome and Healthy Controls, International Journal of Preventive Medicine (2012)
44. Prevalence of Familial Multiple Sclerosis in Isfahan, Iran, Journal of Isfahan Medical School (2011)
45. The Effectiveness of Natalizumab Vs Fingolimod–A Comparison of International Registry Studies, Multiple Sclerosis and Related Disorders (2021)
46. Multiple Sclerosis: Pathophysiology, Clinical Features, Diagnosis, and Management, Neuroinflammation (2011)
47. Evaluation of the Prevalence of Bovine Leukemia Virus Dna in Peripheral Blood Mononuclear Cells of Multiple Sclerosis Patients, IJID Regions (2023)
48. Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis, JAMA - Journal of the American Medical Association (2019)
49. Elevated Csf Concentration of Ccl3 and Ccl4 in Relapsing Remitting Multiple Sclerosis Patients, Journal of Immunoassay and Immunochemistry (2019)
50. Multiple Sclerosis Is Associated With Worse Covid-19 Outcomes Compared to the General Population: A Population-Based Study, Multiple Sclerosis and Related Disorders (2023)